Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. ETHK Labs's shares outstanding for the quarter that ended in Dec. 2025 was 1,602 Mil.
ETHK Labs's quarterly shares outstanding
declined
from Jun. 2025 (1,619 Mil) to Dec. 2025 (1,602 Mil).
It means ETHK Labsbought back shares from Jun. 2025 to Dec. 2025 .
ETHK Labs's annual shares outstanding
declined
from Dec. 2024 (1,623 Mil) to Dec. 2025 (1,602 Mil).
It means ETHK Labsbought back shares from Dec. 2024 to Dec. 2025 .
A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.
Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.
Be Aware
Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.
Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.
If net earnings is less than 10%, likely to be in a highly competitive business.
ETHK Labs Shares Outstanding (EOP) Related Terms
ETHK Labs Shares Outstanding (EOP) Historical Data
* Premium members only.
The historical data trend for ETHK Labs's Shares Outstanding (EOP) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01931 vs MCK, COR, CAH: Shares Outstanding (EOP) Comparison
For the Medical Distribution subindustry, ETHK Labs's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ETHK Labs Shares Outstanding (EOP) vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, ETHK Labs's Shares Outstanding (EOP) distribution charts can be found below:
* The bar in red indicates where ETHK Labs's Shares Outstanding (EOP) falls into.
Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.
Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.
What does a Shares Outstanding (EOP) of 1,602 Mil mean?
ETHK Labs (HKSE:01931) has a Shares Outstanding (EOP) of 1,602 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on ETHK Labs and its competitors.
Is ETHK Labs' Shares Outstanding (EOP) too high?
ETHK Labs' current Shares Outstanding (EOP) is 1,602 Mil. Overall, ETHK Labs has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ETHK Labs' Shares Outstanding (EOP) compare to MCK and COR?
ETHK Labs' Shares Outstanding (EOP) of 1,602 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Distribution company?
A good Shares Outstanding (EOP) depends on the Medical Distribution industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on ETHK Labs and its competitors. ETHK Labs's current Shares Outstanding (EOP) is 1,602 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ETHK Labs stock overvalued right now?
Based on GuruFocus' analysis, ETHK Labs (HKSE:01931) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.38, compared to a current price of HK$0.59 — trading 57.2% below its estimated fair value. The current Shares Outstanding (EOP) is 1,602 Mil. ETHK Labs' overall GF Score™ is 74/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For ETHK Labs (HKSE:01931), the current Shares Outstanding (EOP) is 1,602 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ETHK Labs (HKSE:01931) Overvalued in 2026?
Based on GuruFocus' analysis, ETHK Labs stock appears to be undervalued.
The current stock price of HK$0.59 is trading 57.2% below its estimated GF Value™ of HK$1.38.
GuruFocus considers ETHK Labs to be Possible Value Trap.
Key valuation signals for HKSE:01931:
Shares Outstanding (EOP): 1,602 Mil
GF Value™: HK$1.38 vs. price of HK$0.59 (57.2% below fair value)
No single metric tells the full story. See the HKSE:01931 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ETHK Labs Inc is engaged in the distribution, after-sales service, and development of in-vitro diagnostic (IVD) products in China. The company operates through three business segments: Distribution Business, After-sales Services, and Self-branded Products Business. It distributes IVD analysers, reagents, and consumables to hospitals and healthcare institutions, provides maintenance and installation services for diagnostic equipment, and develops and sells self-branded IVD analysers and reagents. The company generates the majority of its revenue from Mainland China.
74GF Score
Get the complete analysis for HKSE:01931
Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01931 has been successfully added to your 
